U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. CPG 230.120- Human Blood and Blood Products as Drugs
  1. Search for FDA Guidance Documents

COMPLIANCE POLICY GUIDE (CPG)

CPG 230.120- Human Blood and Blood Products as Drugs October 1980

Final
Issued by:
Guidance Issuing Office
Office of the Commissioner, Office of Policy, Legislation, and International Affairs, Office of Global Policy and Strategy, Office of Gobal Operations, Latin America Office, DO NOT USE - Terms Set to be Removed, DO NOT USE - Office of the Associate Commissioner for Regulatory Affairs

Compliance Policy Guide Sec. 230.120- Human Blood and Blood Products As Drugs is obsolete and was withdrawn on 1/30/2020.

Issued 6/17/74
Revised 10/1/80
Withdrawn: 1/30/2020

 


Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.